Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carnitine palmitoyltransferase deficiencies.

J P Bonnefont1, F Demaugre, C Prip-Buus

  • 1Genetic Biochemistry Unit, CHU Necker-Enfants Malades, Paris, France. Bonnfont@necker.fr

Molecular Genetics and Metabolism
|December 23, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The alternative NF-κB RelB subunit is a novel critical sensor of lipid metabolism to promote tumor development.

Cell death & disease·2026
Same author

[New insights in inborn errors of metabolism are leading to new paradigms in child neurology].

Revista de neurologia·2018
Same author

A novel LKB1 isoform enhances AMPK metabolic activity and displays oncogenic properties.

Oncogene·2014
Same author

GH administration rescues fatty liver regeneration impairment by restoring GH/EGFR pathway deficiency.

Endocrinology·2014
Same author

Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases.

Journal of inherited metabolic disease·2012
Same author

Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency.

Molecular genetics and metabolism·2011

Carnitine palmitoyltransferase (CPT) deficiencies disrupt fatty acid oxidation. CPT1 and CPT2 deficiencies present with varied symptoms, including hypoglycemia and rhabdomyolysis, requiring dietary and lifestyle management.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Carnitine palmitoyltransferase (CPT) deficiencies are inherited disorders affecting mitochondrial fatty acid oxidation.
  • The CPT system comprises CPT1 (outer mitochondrial membrane) and CPT2 (inner mitochondrial membrane) proteins, with CPT1 having liver (L) and muscle (M) isoforms.

Purpose of the Study:

  • To review the clinical presentations, genetic basis, and management of CPT deficiencies.
  • To highlight the distinct phenotypes associated with CPT1 and CPT2 deficiencies.

Main Methods:

  • Literature review of reported cases and genetic mutations.
  • Analysis of clinical presentations, including hypoglycemia, rhabdomyolysis, and dysmorphogenesis.
  • Summary of current treatment strategies and diagnostic approaches.

Related Experiment Videos

Main Results:

  • L-CPT1 deficiency causes fasting hypoketotic hypoglycemia.
  • CPT2 deficiency presents with diverse phenotypes: adult myopathic form (rhabdomyolysis), infantile form (hypoglycemia, cardiac damage), and neonatal form (lethal dysmorphogenesis).
  • Specific mutations, like S113L in CPT2, are prevalent.

Conclusions:

  • CPT deficiencies represent a spectrum of metabolic disorders with significant clinical variability.
  • Management focuses on dietary interventions and avoiding triggers like fasting and prolonged exercise.
  • Prenatal diagnosis is available for at-risk pregnancies.